Uveitis: Clinical Trials

237 completed, 92 unknown, 41 recruiting, 35 terminated. 103 Phase 2, 67 Phase 3, 59 Not applicable, 43 Phase 1, 35 Phase 4.

By phase and status

Phase	Trials	Status
Phase 2	103	Completed 55, Terminated 14, Unknown 12, Withdrawn 9, Recruiting 8, Not yet recruiting 3, Active not recruiting 1, Suspended 1
Phase 3	67	Completed 35, Terminated 13, Unknown 9, Recruiting 4, Withdrawn 3, Active not recruiting 2, Not yet recruiting 1
Not applicable	59	Completed 29, Unknown 18, Recruiting 6, Withdrawn 3, Terminated 2, Active not recruiting 1
Phase 1	43	Completed 21, Terminated 6, Unknown 5, Recruiting 4, Withdrawn 4, Enrolling by invitation 1, Not yet recruiting 1, Suspended 1
Phase 4	35	Completed 13, Unknown 9, Not yet recruiting 4, Terminated 4, Withdrawn 3, Active not recruiting 2
Early Phase 1	2	Completed 2

Follow Uveitis: new trials by email Literature Review of Uveitis trials Research Report on Uveitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis Blood sample, Adalimumab Injection - Uveitis, Chronic Disease	Phase 4	Not yet recruiting	Centre Hospitalier Universitaire de Saint Etienne	320	2026-12-01	2026-07-10
Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II Valganciclovir, Ganciclovir (GCV), Placebo - Cytomegalovirus (CMV), Anterior Uveitis	Phase 2	Not yet recruiting	University of California, San Francisco	117	2026-11-01	2026-08-11
A Clinical Trial Of Tulisokibart In Participants With Active, Non-Infectious Uveitis (MK-7240-019) Tulisokibart, Placebo, Background prednisone therapy - Noninfectious Intermediate, Posterior, or Panuveitis	Phase 2	Not yet recruiting	Merck Sharp & Dohme LLC	87	2026-10-27	2026-10-06
Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut Behçet's Disease		Not yet recruiting	Assiut University	30	2026-09-30	2025-09-05
Serum EBI-3 Protein Levels in Behçet's Disease Behçet Disease		Not yet recruiting	Assiut University	90	2026-09-26	2026-09-28
PANDA-ASOCT: Paediatric Anterior Uveitis Detection With Automated Image Analysis Using ASOCT Slit Lamp Examination, Anterior segment ocular coherence tomography (ASOCT) - Uveitis		Recruiting	Sheffield Children's NHS Foundation Trust	300	2026-09-09	2026-09-15
Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research Pericarditis, Tako-TSUBO Cardiomyopathy		Not yet recruiting	Assistance Publique - Hôpitaux de Paris	300	2026-09-01	2026-08-10
Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym. Repository Corticotropin Injection (ACTH), Study-matched inactive placebo injection, also called control injection - Behçet's Syndrome, Behçet's Syndrome (BS)	Phase 2	Not yet recruiting	Peking University People's Hospital	60	2026-09-01	2026-09-22
Asprosin in Behect Patients Behcet Disease		Not yet recruiting	Assiut University	44	2026-09-01	2026-09-03
Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial Adalimumab/Biosimilar - Juvenile Idiopathic Arthritis Associated Uveitis, Uveitis, Anterior	Phase 4	Not yet recruiting	Nisha Acharya	160	2026-09-01	2026-07-13
Ocular Fluid Work-up in Presumed Trematode Induced Granulomatous Uveitis AC fluid sample, Vitreous fluid sample - Presumed Trematode Induced Uveitis, Uveitis		Recruiting	Kasr El Aini Hospital	40	2026-09-01	2026-10-21
A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis. GenSci048, Placebo - Uveitis	Phase 2	Recruiting	Changchun GeneScience Pharmaceutical Co., Ltd.	74	2026-06-29	2026-07-24
Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus diet restriction - Behcet Disease, Obesity	Not applicable	Recruiting	Cairo University	40	2026-06-04	2026-07-14
Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease treadmill walking - Metabolic Syndrome, Behcet Disease	Not applicable	Recruiting	Cairo University	40	2026-06-02	2026-07-14
Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated With a Fluocinolone Acetonide Implant fluocinolone acetonide intravitreal implant - Noninfectious Posterior Uveitis, Uveitis, Posterior		Not yet recruiting	Nantes University Hospital	100	2026-06-01	2026-06-24
Ivarmacitinib for Refractory Behcet's Syndrome Ivarmacitinib - Behcet's Syndrome	Phase 2	Withdrawn	Liu Tian		2026-06-01	2026-07-10
Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing inspiratory muscle trianing - Behcet Disease	Not applicable	Recruiting	Cairo University	40	2026-05-06	2026-06-23
Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis Upadacitinib 15 MG [Rinvoq] - Axial Spondylarthritis (axSpA)	Phase 4	Not yet recruiting	CARE ARTHRITIS LTD.	200	2026-05-01	2026-02-06
Real-World Incidence of Intraocular Inflammation Following Intravitreal Treatment With Aflibercept 8 mg Aflibercept (Eylea) - Intraocular Inflammation, Intravitreal Injections		Completed	Copenhagen University Hospital, Rigshospitalet	3690	2026-04-20	2026-09-30
A Study of Uveitis in Children <18 Years of Age Uveitis		Recruiting	Jaeb Center for Health Research	300	2026-04-14	2026-05-08

Showing 20 of 460. Sign in to see all of them.

Narrower conditions

Behcet Syndrome (131)  ·  Uveitis, Posterior (60)  ·  Uveitis, Intermediate (56)  ·  Uveitis, Anterior (48)  ·  Macular Edema (42)  ·  Panuveitis (37)  ·  Inflammation (20)  ·  Arthritis, Juvenile (15)  ·  Spondylitis, Ankylosing (13)  ·  Takayasu Arteritis (13)  ·  Uveomeningoencephalitic Syndrome (13)  ·  Arthritis, Rheumatoid (11)  ·  Retinal Vasculitis (11)  ·  Diabetic Retinopathy (10)

Broader conditions

Uveal Diseases (459)  ·  Eye Diseases (454)  ·  Panuveitis (215)  ·  Vascular Diseases (154)  ·  Cardiovascular Diseases (152)  ·  Skin and Connective Tissue Diseases (148)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (142)  ·  Genetic Diseases, Inborn (139)  ·  Skin Diseases (138)  ·  Uveitis, Anterior (134)  ·  Skin Diseases, Vascular (133)  ·  Mouth Diseases (132)  ·  Stomatognathic Diseases (132)  ·  Skin Diseases, Genetic (131)

Interventions

Adalimumab (24)  ·  Methotrexate (15)  ·  Fluocinolone Acetonide (10)  ·  Triamcinolone Acetonide (10)  ·  Mycophenolic Acid (9)  ·  Prednisone (9)  ·  Cyclosporine (8)  ·  Daclizumab (8)  ·  Dexamethasone (8)  ·  Infliximab (8)  ·  secukinumab (8)  ·  Adrenal Cortex Hormones (7)  ·  prednisolone acetate (7)  ·  Adrenocorticotropic Hormone (6)  ·  Bevacizumab (6)

Sponsors

National Eye Institute (NEI) (43)  ·  Assiut University (23)  ·  Assistance Publique - Hôpitaux de Paris (15)  ·  Novartis Pharmaceuticals (11)  ·  Benha University (9)  ·  Oregon Health and Science University (8)  ·  St. Franziskus Hospital (8)  ·  Peking Union Medical College Hospital (7)  ·  Sun Yat-sen University (6)  ·  Tehran University of Medical Sciences (6)  ·  Tianjin Medical University (6)  ·  University of California, San Francisco (6)  ·  AbbVie (5)  ·  Cairo University (5)  ·  Clearside Biomedical, Inc. (5)

Countries

United States (169)  ·  France (49)  ·  China (43)  ·  Germany (39)  ·  Turkey (Türkiye) (39)  ·  United Kingdom (36)  ·  Egypt (30)  ·  Spain (24)  ·  Italy (23)  ·  India (19)  ·  Israel (18)  ·  Australia (15)  ·  Austria (15)  ·  Brazil (14)  ·  Greece (14)

Top investigators

Hatice N Sen, M.D. (8)  ·  Nisha Acharya, MD MS (5)  ·  Fereydoun Davatchi, MD (4)  ·  Peter A. Merkel, MD, MPH (4)  ·  Quan D Nguyen, MD, MSc (4)  ·  Thomas Ciulla, MD (4)  ·  Ali MA Ismail, lecturer (3)  ·  Amanda M. Terry, MA (3)  ·  Arnd Heiligenhaus, MD (3)  ·  Bahar Sadeghi, MD (3)  ·  Eddy Anglade, M.D. (3)  ·  Emily Y Chew, M.D. (3)

Results publications

PMID 37172782, PMID 23290985, PMID 36787524, PMID 19248087, PMID 20498207, PMID 21622969, PMID 21885496, PMID 28426849, PMID 36399237, PMID 37316690, PMID 38925285, PMID 11152054, PMID 11459787, PMID 12095806, PMID 12441176, PMID 14078870, PMID 14078872, PMID 15079763, PMID 15161982, PMID 16009830, PMID 16019682, PMID 16054041, PMID 16406545, PMID 16461435, PMID 16545455, PMID 16687455, PMID 16998234, PMID 17130214, PMID 17159027, PMID 17337065, PMID 17353400, PMID 17620582, PMID 17960403, PMID 18046222, PMID 18343349, PMID 18639220, PMID 18682970, PMID 18992868, PMID 19026127, PMID 19118701, PMID 19184312, PMID 19211094, PMID 19268890, PMID 19427992, PMID 19506209, PMID 19597921, PMID 19664754, PMID 19668980, PMID 1970380, PMID 19717547

NIH funding

2009 (10), 2023 (3), 2014 (2), 2016 (2), 2025 (2), U10EY024527 (2), 2005 (1), 2018 (1), 2019 (1), R21EY036563 (1), R44EY014772 (1), U10EY014660 (1), U10EY021125 (1), UG1EY029658 (1), UG1EY036344 (1)